Stoke Therapeutics Stock (NASDAQ: STOK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.000 / 1.180M |
Day Range | - - - |
52 Wk Range | 3.350 - 16.400 |
Market Cap | $609.254M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 14.29% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Stoke Therapeutics (NASDAQ: STOK) through any online brokerage.
Other companies in Stoke Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).
The latest price target for Stoke Therapeutics (NASDAQ: STOK) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 22.00 expecting STOK to rise to within 12 months (a possible 88.20% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $11.69 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Stoke Therapeutics.
Stoke Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Stoke Therapeutics.
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.